Skip to content

Latest Post

Ozempic NAION Warning: FDA Adds Rare Eye Risk to Every GLP-1 Drug Label India’s First Zika Vaccine Wins CDSCO Panel Nod for Phase I Trial Rezatapopt Ovarian Cancer Data: p53 Pill Shrinks Tumours in 48% of Platinum-Resistant Patients GLP-1 Heart Failure Study: Semaglutide and Tirzepatide Remodel Weak Hearts Beyond Weight Loss Manipur Liquor Tragedy: Toll Hits 15 as 300+ Treated for Suspected Methanol Poisoning
  • Sun. Nov 22nd, 2026
MedGadget.in logo – medical technology news and healthcare technology insights

  • Home
  • About Us
  • Author
  • Contact Us
Pharmaceutical

Ozempic NAION Warning: FDA Adds Rare Eye Risk to Every GLP-1 Drug Label

November 21, 2026 Simone Lamb

The FDA now requires all 12 GLP-1 drugs, including Ozempic, Wegovy and Mounjaro, to warn of NAION, a rare cause of sudden vision loss. Here…

Clinical Trials

India’s First Zika Vaccine Wins CDSCO Panel Nod for Phase I Trial

November 21, 2026 Simone Lamb

A CDSCO expert panel recommended a Phase I trial of Indian Immunologicals' live attenuated Zika vaccine, developed with Griffith University and funded by ICMR.

Clinical Trials

Rezatapopt Ovarian Cancer Data: p53 Pill Shrinks Tumours in 48% of Platinum-Resistant Patients

November 21, 2026 Simone Lamb

PMV Pharmaceuticals' rezatapopt produced a 48% response rate in platinum-resistant ovarian cancer with TP53 Y220C in the pivotal PYNNACLE trial, with an FDA filing planned…

Clinical Trials

GLP-1 Heart Failure Study: Semaglutide and Tirzepatide Remodel Weak Hearts Beyond Weight Loss

November 21, 2026 Simone Lamb

Mayo Clinic data from ObesityWeek 2026 show GLP-1 users with weakened hearts saw greater one-year gains in heart structure and function than matched non-users, with…

Healthcare Services

Manipur Liquor Tragedy: Toll Hits 15 as 300+ Treated for Suspected Methanol Poisoning

November 21, 2026 Simone Lamb

Up to 15 people have died and more than 300 have sought care in Imphal after drinking spurious liquor in Manipur's Chandel district. What we…

Pharmaceutical

Ozempic NAION Warning: FDA Adds Rare Eye Risk to Every GLP-1 Drug Label

November 21, 2026 Simone Lamb

The FDA now requires all 12 GLP-1 drugs, including Ozempic, Wegovy and Mounjaro, to warn…

Healthcare Services

Pope Leo XIV Lung Surgery: Early Nodule, 1-Week Recovery

October 12, 2026 Simone Lamb

Pope Leo XIV lung surgery set after doctors found an early-stage nodule. What the Vatican said, what is unknown and what a lung nodule means.

Healthcare Services

Kenya Ebola Outbreak October 2026: 0 New Cases in 293 Tests

October 12, 2026 Simone Lamb

Kenya Ebola outbreak October 2026 update: no new cases after 293 tests, 108 contacts in quarantine, as the Congo outbreak continues.

Medical Device

Philips Sleep Apnea Device Recall: 15M Units, Court Win

October 11, 2026 Simone Lamb

Philips sleep apnea device recall: a Dutch court rejected shareholders’ bid for an inquiry. What it means for 15 million devices and patients.

Healthcare Services

Russia Plague Lab WHO Report: No Spread Found, 5,500 Tests

October 11, 2026 Simone Lamb

The Russia plague lab WHO report finds no evidence of spread after a lab worker’s death in Irkutsk; cause remains undetermined. Key findings.

Pharmaceutical

How to Know If You Were Exposed to Measles: 6 Key Steps

October 10, 2026 Simone Lamb

Think you were exposed to measles? Learn the signs of exposure, symptom timeline, immunity checks and steps to take, from CDC and WHO guidance.

Pharmaceutical

Largest Measles Outbreak in Decades: Pennsylvania Tops 1,000

October 10, 2026 Simone Lamb

Pennsylvania’s outbreak is the largest measles outbreak in decades for a US state, with over 1,000 cases. How it compares, deaths and vaccine uptake.

Pharmaceutical

US Measles Cases Top 4,000 in 45 States: Worst Since 1991

October 10, 2026 Simone Lamb

US measles cases passed 4,000 in 2026, with infections in 45 states and DC, CDC data show. The numbers, the hotspots and what the data cannot say.

Pharmaceutical

340B Drug Pricing Program Lawsuit: $1B Cost Fight Revealed

October 10, 2026 Simone Lamb

The 340B Drug Pricing Program lawsuit by the AHA targets a federal rebate model that hospitals say would add over $1 billion a year in costs.

Pharmaceutical

Hovilpri FDA Approval: 63% Healing Rate Revealed

October 10, 2026 Simone Lamb

Hovilpri FDA approval gives immunocompromised adults an oral option for HSV lesions that resist standard antivirals. Trial data, dosing, safety, launch.

Pharmaceutical

Once-Monthly Olanzapine Injection: 1st FDA Approval Revealed

October 10, 2026 Simone Lamb

The once-monthly olanzapine injection Weltruza gets FDA approval for adults with schizophrenia. Doses, SOLARIS data, safety and launch timing.

Posts pagination

1 … 26 27 28 … 36

You missed

Pharmaceutical

Ozempic NAION Warning: FDA Adds Rare Eye Risk to Every GLP-1 Drug Label

November 21, 2026 Simone Lamb
Clinical Trials

India’s First Zika Vaccine Wins CDSCO Panel Nod for Phase I Trial

November 21, 2026 Simone Lamb
Clinical Trials

Rezatapopt Ovarian Cancer Data: p53 Pill Shrinks Tumours in 48% of Platinum-Resistant Patients

November 21, 2026 Simone Lamb
Clinical Trials

GLP-1 Heart Failure Study: Semaglutide and Tirzepatide Remodel Weak Hearts Beyond Weight Loss

November 21, 2026 Simone Lamb
MedGadget.in logo – medical technology news and healthcare technology insights

Proudly powered by WordPress | Theme: NewsTwenty by Themeansar.

  • Home
  • About Us
  • Author
  • Contact Us